Published in Biochemistry on August 21, 2001
Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.40
Substrate interactions with human ferrochelatase. Proc Natl Acad Sci U S A (2007) 1.14
A pi-helix switch selective for porphyrin deprotonation and product release in human ferrochelatase. J Mol Biol (2007) 1.06
Electron paramagnetic resonance and Mössbauer spectroscopy of intact mitochondria from respiring Saccharomyces cerevisiae. J Biol Inorg Chem (2007) 1.05
Identification of [2Fe-2S] clusters in microbial ferrochelatases. J Bacteriol (2002) 1.03
A general map of iron metabolism and tissue-specific subnetworks. Mol Biosyst (2009) 1.02
Porphyrin binding and distortion and substrate specificity in the ferrochelatase reaction: the role of active site residues. J Mol Biol (2008) 0.99
Direct measurement of metal ion chelation in the active site of human ferrochelatase. Biochemistry (2007) 0.97
Product release rather than chelation determines metal specificity for ferrochelatase. J Mol Biol (2009) 0.96
Erythroid heme biosynthesis and its disorders. Cold Spring Harb Perspect Med (2013) 0.95
Metal binding to Bacillus subtilis ferrochelatase and interaction between metal sites. J Biol Inorg Chem (2003) 0.92
Metal ion substrate inhibition of ferrochelatase. J Biol Chem (2008) 0.91
Interdomain lateral gene transfer of an essential ferrochelatase gene in human parasitic nematodes. Proc Natl Acad Sci U S A (2013) 0.91
Altered orientation of active site residues in variants of human ferrochelatase. Evidence for a hydrogen bond network involved in catalysis. Biochemistry (2007) 0.88
Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases. Blood (2005) 0.88
Proteobacteria-like ferrochelatase in the malaria parasite. Curr Genet (2003) 0.83
Metal ion selectivity and substrate inhibition in the metal ion chelation catalyzed by human ferrochelatase. J Biol Chem (2009) 0.82
Evolution in a family of chelatases facilitated by the introduction of active site asymmetry and protein oligomerization. Proc Natl Acad Sci U S A (2010) 0.81
Oxidative stress and the homeodynamics of iron metabolism. Biomolecules (2015) 0.79
FERROCHELATASE: THE CONVERGENCE OF THE PORPHYRIN BIOSYNTHESIS AND IRON TRANSPORT PATHWAYS. J Porphyr Phthalocyanines (2011) 0.77
Paralytic ileus and liver failure--an unusual presentation of advanced erythropoietic protoporphyria. Dig Dis Sci (2008) 0.76
Identification and characterization of solvent-filled channels in human ferrochelatase. Biochemistry (2012) 0.75
Is it possible for Fe2+ to approach protoporphyrin IX from the side of Tyr-13 in Bacillus subtilis ferrochelatase? An answer from QM/MM study. J Mol Model (2012) 0.75
Investigation by MD simulation of the key residues related to substrate-binding and heme-release in human ferrochelatase. J Mol Model (2013) 0.75
Reduction of iron and synthesis of protoheme by Spirillum itersonii and other organisms. J Bacteriol (1977) 3.39
Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med (1998) 2.32
The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis. Nat Struct Biol (2001) 1.96
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet (1996) 1.78
Bovine ferrochelatase. Kinetic analysis of inhibition by N-methylprotoporphyrin, manganese, and heme. J Biol Chem (1983) 1.78
Organization of the terminal two enzymes of the heme biosynthetic pathway. Orientation of protoporphyrinogen oxidase and evidence for a membrane complex. J Biol Chem (1988) 1.61
Ferrochelatase at the millennium: structures, mechanisms and [2Fe-2S] clusters. Cell Mol Life Sci (2000) 1.38
Crystal structure of the transcription factor sc-mtTFB offers insights into mitochondrial transcription. Protein Sci (2001) 1.33
Orientation of ferrochelatase in bovine liver mitochondria. Biochemistry (1985) 1.32
Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem J (1984) 1.30
Purification and characterization of murine protoporphyrinogen oxidase. Biochemistry (1987) 1.21
Mouse protoporphyrinogen oxidase. Kinetic parameters and demonstration of inhibition by bilirubin. Biochem J (1988) 1.16
Orientation of the carboxyl and NH2 termini of the membrane-binding segment of cytochrome b5 on the same side of phospholipid bilayers. J Biol Chem (1981) 1.15
Expression of mammalian 5-aminolevulinate synthase in Escherichia coli. Overproduction, purification, and characterization. J Biol Chem (1993) 1.14
Expression of a cloned protoporphyrinogen oxidase. J Biol Chem (1994) 1.14
Human protoporphyrinogen oxidase: expression, purification, and characterization of the cloned enzyme. Protein Sci (1996) 1.13
Purification and characterization of the membrane-bound ferrochelatase from Spirillum itersonii. J Bacteriol (1977) 1.12
Aerobic ferrisiderophore reductase assay and activity stain for native polyacrylamide gels. Anal Biochem (1983) 1.10
Site-directed mutagenesis and spectroscopic characterization of human ferrochelatase: identification of residues coordinating the [2Fe-2S] cluster. Biochemistry (1996) 1.10
Purification and characterization of membrane-bound ferrochelatase from Rhodopseudomonas sphaeroides. J Biol Chem (1982) 1.09
Purification and characterization of mammalian and chicken ferrochelatase. Methods Enzymol (1986) 1.08
Function of the [2FE-2S] cluster in mammalian ferrochelatase: a possible role as a nitric oxide sensor. Biochemistry (1996) 1.08
Ferric iron reductase of Rhodopseudomonas sphaeroides. J Bacteriol (1985) 1.07
Ferrochelatase activity in wild-type and mutant strains of Spirillum itersonii. Solubilization with chaotropic reagents. Arch Biochem Biophys (1974) 1.07
In situ conversion of coproporphyrinogen to heme by murine mitochondria: terminal steps of the heme biosynthetic pathway. Protein Sci (1993) 1.06
Identification of an FAD superfamily containing protoporphyrinogen oxidases, monoamine oxidases, and phytoene desaturase. Expression and characterization of phytoene desaturase of Myxococcus xanthus. J Biol Chem (1998) 1.05
A molecular defect in human protoporphyria. Am J Hum Genet (1992) 1.04
Heme biosynthesis in mammalian systems: evidence of a Schiff base linkage between the pyridoxal 5'-phosphate cofactor and a lysine residue in 5-aminolevulinate synthase. Protein Sci (1993) 1.04
Structural and functional properties of the membrane binding segment of cytochrome b5. J Biol Chem (1978) 1.04
Evidence that the fourth ligand to the [2Fe-2S] cluster in animal ferrochelatase is a cysteine. Characterization of the enzyme from Drosophila melanogaster. J Biol Chem (1998) 1.03
Siderophore utilization and iron uptake by Rhodopseudomonas sphaeroides. Arch Biochem Biophys (1984) 1.03
Multiple mechanisms for the regulation of haem synthesis during erythroid cell differentiation. Possible role for coproporphyrinogen oxidase. Biochem J (1991) 1.02
Regulation of heme biosynthesis in Escherichia coli. Arch Biochem Biophys (1995) 1.02
Protoporphyrinogen oxidase of Myxococcus xanthus. Expression, purification, and characterization of the cloned enzyme. J Biol Chem (1996) 1.01
Purification and characterization of bacterial ferrochelatase. Methods Enzymol (1986) 1.01
The synthesis of murine ferrochelatase in vitro and in vivo. Biochem J (1988) 1.00
Characterization of the interaction of amphipathic cytochrome b5 with stearyl coenzyme A desaturase and NADPH:cytochrome P-450 reductase. J Biol Chem (1980) 1.00
Membrane-bound respiratory of Spirillum itersonii. J Bacteriol (1976) 1.00
Human ferrochelatase: crystallization, characterization of the [2Fe-2S] cluster and determination that the enzyme is a homodimer. Biochim Biophys Acta (1999) 1.00
Direct measurement of metal ion chelation in the active site of human ferrochelatase. Biochemistry (2007) 0.97
Purification of and kinetic studies on a cloned protoporphyrinogen oxidase from the aerobic bacterium Bacillus subtilis. Arch Biochem Biophys (1998) 0.95
Crystal structure of the neurophysin-oxytocin complex. Nat Struct Biol (1996) 0.94
Examination of the activity of carboxyl-terminal chimeric constructs of human and yeast ferrochelatases. Biochemistry (2000) 0.93
Mammalian ferrochelatase. Expression and characterization of normal and two human protoporphyric ferrochelatases. J Biol Chem (1994) 0.93
Biphasic ordered induction of heme synthesis in differentiating murine erythroleukemia cells: role of erythroid 5-aminolevulinate synthase. Mol Cell Biol (1993) 0.91
Iron transport and its relation to heme biosynthesis in Rhodopseudomonas sphaeroides. J Bacteriol (1985) 0.91
Cloning, sequence, and expression of mouse protoporphyrinogen oxidase. Arch Biochem Biophys (1995) 0.91
Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease. J Med Genet (2004) 0.91
Effect of sulfhydryl group modification on the activity of bovine ferrochelatase. J Biol Chem (1984) 0.90
Spectroscopic examination of the active site of bovine ferrochelatase. Biochemistry (1985) 0.90
The primary structure of the nonpolar segment of bovine cytochrome b5. J Biol Chem (1978) 0.90
Effect of cellular location on the function of ferrochelatase. J Biol Chem (1995) 0.89
Molecular characterization of homozygous variegate porphyria. Hum Mol Genet (1998) 0.89
Effect of beef tenderness on consumer satisfaction with steaks consumed in the home and restaurant. J Anim Sci (1996) 0.89
Purification and characterization of chicken erythrocyte ferrochelatase. Biochem J (1984) 0.88
Expression and characterization of the terminal heme synthetic enzymes from the hyperthermophile Aquifex aeolicus. FEMS Microbiol Lett (2001) 0.88
Modification and identification of cytochrome b5 carboxyl groups involved in protein-protein interaction with cytochrome b5 reductase. J Biol Chem (1979) 0.88
Cloning and characterization of Gallus and Xenopus ferrochelatases: presence of the [2Fe-2S] cluster in nonmammalian ferrochelatase. Arch Biochem Biophys (1998) 0.86
Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease. J Neuropathol Exp Neurol (1998) 0.85
Reconstitution of the two terminal enzymes of the heme biosynthetic pathway into phospholipid vesicles. J Biol Chem (1987) 0.85
Ferrochelatase from Rhodopseudomonas sphaeroides: substrate specificity and role of sulfhydryl and arginyl residues. J Bacteriol (1986) 0.85
Selective cell loss in Edinger-Westphal in asymptomatic elders and Alzheimer's patients. Neurobiol Aging (2001) 0.85
Physical factors influencing fluid reabsorption from Henle's loop. Can J Physiol Pharmacol (1975) 0.84
Human coproporphyrinogen oxidase is not a metalloprotein. J Biol Chem (1996) 0.83
Crystallization and preliminary crystallographic data for the augmenter of liver regeneration. Acta Crystallogr D Biol Crystallogr (1997) 0.83
Erythroid 5-aminolevulinate synthase is required for erythroid differentiation in mouse embryonic stem cells. Blood Cells Mol Dis (1998) 0.83
Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivity in Alzheimer's disease. Acta Neuropathol (1999) 0.83
Yeast ferrochelatase: expression in a baculovirus system and purification of the expression protein. Protein Sci (1992) 0.83
N-Methylprotoporphyrin is a more potent inhibitor of recombinant human than of recombinant chicken ferrochelatase. Drug Metab Dispos (2000) 0.82
The role of arginyl residues in porphyrin binding to ferrochelatase. J Biol Chem (1986) 0.81
A new mutation of the ALAS2 gene in a large family with X-linked sideroblastic anemia. Hum Genet (1995) 0.81
Characteristics of murine protoporphyrinogen oxidase. Protein Sci (1992) 0.81
Inhibition of ferrochelatase during differentiation of murine erythroleukaemia cells. Biochem J (1987) 0.81
Expression, purification, and characterization of recombinant mammalian ferrochelatase. Methods Enzymol (1997) 0.80
The role of COOH-terminal anionic residues in binding cytochrome b5 to phospholipid vesicles and biological membranes. J Biol Chem (1981) 0.80
Multiple regulatory steps in erythroid heme biosynthesis. Arch Biochem Biophys (2000) 0.79
Purification, crystallization and preliminary X-ray analysis of Drosophila melanogaster ferrochelatase. Acta Crystallogr D Biol Crystallogr (1999) 0.79
Serum-free, defined medium for the growth and differentiation of murine erythroleukemia cells. Biotechniques (1992) 0.78
Expression, purification, and characteristics of mammalian protoporphyrinogen oxidase. Methods Enzymol (1997) 0.78
Examination of ferrochelatase mutations that cause erythropoietic protoporphyria. Blood (1998) 0.78
Variegate porphyria in South Africa, 1688-1996--new developments in an old disease. S Afr Med J (1997) 0.77
Diagnosis of hyperlipidemia and treatment with a statin in the outpatient stroke clinic. J Stroke Cerebrovasc Dis (2007) 0.77
Peroxidase activity of cytochrome C facilitates the protoporphyrinogen oxidase reaction. Cell Mol Biol (Noisy-le-grand) (2009) 0.76
Use of recombinant human ferrochelatase as a sensitive bioassay for N-alkylprotoporphyrin IX formed after interaction of porphyrinogenic xenobiotics with rat liver microsomes. Can J Physiol Pharmacol (2000) 0.76
Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases. Chang Gung Med J (2001) 0.76
Clinical characteristics of outpatients at a psycho-oncology clinic in a radiation oncology department. Chang Gung Med J (2001) 0.76
Positive inotropic and toxic action of direct lytic factor on isolated working guinea pig hearts. Zhongguo Yao Li Xue Bao (1991) 0.75
Generation of resistance to the diphenyl ether herbicide acifluorfen by MEL cells. Biochem Biophys Res Commun (1995) 0.75
Oblique sliding metatarsal osteotomy for pressure metatarsalgia. Gaoxiong Yi Xue Ke Xue Za Zhi (1992) 0.75